« CTIX Home | Email msg. | Reply to msg. | Post new | Board info. Previous | Home | Next

up over 30% on today news 

By: zzpage in CTIX | Recommend this post (4)
Tue, 09 Dec 14 2:57 AM | 3185 view(s)
Boardmark this board | Cellceutex Corporation
Msg. 00002 of 00004
Jump:
Jump to board:
Jump to msg. #

U.S. Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) designation for Brilacidin as a new treatment for Acute Bacterial Skin and Skin Structure Infections (ABSSSI


http://finance.yahoo.com/news/cellceutix-antibiotic-brilacidin-receives-qidp-120000123.html

Propeller




» You can also:
« CTIX Home | Email msg. | Reply to msg. | Post new | Board info. Previous | Home | Next